Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Keryx Biopharmaceuticals Inc.

http://www.keryx.com

Latest From Keryx Biopharmaceuticals Inc.

ElevateBio Raises $401m To Fund Its Own And Partners’ Future Cell And Gene Therapy Needs

ElevateBio closed a series D venture capital round and revealed a potentially multibillion-dollar deal between its Life Edit subsidiary and Novo Nordisk as demand for its cell and gene therapy capabilities grow.

Financing Deals

Back From The Dead Biodexa Makes Bid For VarianBio

Having just avoided going into administration, the firm formerly known as Midatech has pivoted its business model from a drug delivery company to a therapeutics player and has hit the acquisition trail.

Commercial Business Strategies

Stock Watch: Pfizer Gets Back To Business As Usual

Sales Of Pfizer’s pandemic products decline as other vaccines are scheduled for a second-half launch but the road back to 2022’s all-time high in annual revenues will not be easy.

Stock Watch Sales & Earnings

Down But Not Out: Nichi-Iko Hives Off Sagent, Exits North America

Seven years after it paid almost three quarters of a billion dollars for US-based Sagent, troubled Nichi-Iko is offloading the struggling business.

M & A Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Access Oncology
    • AOI Pharma, Inc.
UsernamePublicRestriction

Register